Diploma (DPLM) – Research Analysts’ Recent Ratings Changes

A number of research firms have changed their ratings and price targets for Diploma (LON: DPLM):

• 3/27/2026 – Diploma had its price target raised by JPMorgan Chase & Co. from GBX 5,120 to GBX 5,760. They now have a “neutral” rating on the stock.
• 3/23/2026 – Diploma had its price target raised by Jefferies Financial Group Inc. from GBX 5,200 to GBX 5,700. They now have a “hold” rating on the stock.
• 3/19/2026 – Diploma had its price target raised by Berenberg Bank from GBX 6,600 to GBX 7,500. They now have a “buy” rating on the stock.
• 3/19/2026 – Diploma had its price target raised by Deutsche Bank Aktiengesellschaft from GBX 6,200 to GBX 6,400. They now have a “buy” rating on the stock.
• 3/19/2026 – Diploma had its price target raised by Royal Bank Of Canada from GBX 6,200 to GBX 6,600. They now have an “outperform” rating on the stock.
• 3/19/2026 – Diploma had its price target raised by Stifel Nicolaus from GBX 6,200 to GBX 6,800. They now have a “buy” rating on the stock.
• 3/18/2026 – Diploma had its “hold” rating reaffirmed by Shore Capital Group Ltd.

Insider Buying and Selling at Diploma

In other Diploma news, insider Johnny Thomson sold 30,000 shares of the business’s stock in a transaction on Friday, January 16th. The shares were sold at an average price of GBX 5,668, for a total value of £1,700,400. Also, insider Katie Bickerstaffe acquired 352 shares of the company’s stock in a transaction dated Wednesday, January 14th. The stock was acquired at an average price of GBX 5,645 per share, with a total value of £19,870.40. Insiders have acquired 1,352 shares of company stock valued at $7,704,540 in the last 90 days. 1.14% of the stock is currently owned by company insiders.

Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.